Effects of dienogest 0.5, 1, 2 and 3 mg/day on ovarian activity in healthy women.
Phase of Trial: Phase II
Latest Information Update: 29 Nov 2011
At a glance
- Drugs Dienogest (Primary)
- Indications Endometriosis; Menopausal syndrome; Pregnancy
- Focus Pharmacodynamics
- 29 Nov 2011 Results published in the Journal of Clinical Pharmacology.
- 28 Feb 2011 New trial record